Your browser doesn't support javascript.
loading
Show: 20 | 50 | 100
Results 1 - 11 de 11
Filter
1.
Opt Express ; 32(10): 16855-16866, 2024 May 06.
Article in English | MEDLINE | ID: mdl-38858882

ABSTRACT

The increasing line density of the reference grating and the accelerating miniaturization of ultra-precision displacement measurement technology necessitate more stable interferometric signal processing methods for high line density gratings, particularly in low signal-to-noise ratio scenarios. This paper presents a phase demodulation method for dynamic interferometric signals for high line density gratings. The Morlet wavelet transform is utilized to obtain the instantaneous frequency of the interferometric signal, integration of which yields the relative displacement, while adding adjacent relative displacements without gaps provides the absolute displacement during dynamic motion of the grating. In simulations with a signal-to-noise ratio ranging from 40 to 70 dB, the proposed method demonstrates greater robustness compared to the traditional method. By establishing a platform for repeated experiments and comparing it with traditional methods, it was found that the maximum deviation between calculation results obtained using this method and traditional methods is 0.8 nm, further confirming its potential application.

2.
Environ Sci Technol ; 55(19): 13231-13243, 2021 10 05.
Article in English | MEDLINE | ID: mdl-34379386

ABSTRACT

Electrocatalytic reduction has recently received increasing attention as a method of converting waste nitrate into value-added ammonia, but most studies have focused on complex strategies of catalyst preparation and little has been done in the way of large-scale demonstrations. Herein, we report that in situ activation of a pristine Ni electrode, either on a lab scale or a pilot scale, is effective in facilitating nitrate reduction to ammonia, exhibiting extraordinarily high activity, selectivity, and stability. The self-activated Ni cathode has a robust capacity to reduce nitrate over a wide range of concentrations and achieves great conversion yield, NH4+-N selectivity, and Faradaic efficiency, respectively, 95.3, 95.5, and 64.4% at 200 mg L-1 NO3--N and 97.8, 97.1, and 90.4% at 2000 mg L-1 NO3--N, for example. Fundamental research indicates that Ni(OH)2 nanoparticles are formed on the Ni electrode surface upon self-activation, which play crucial roles in governing nitrate reduction reaction (NO3RR) through the atomic H*-mediated pathway and accordingly suppressing hydrogen evolution reaction. More importantly, the self-activated Ni(OH)2@Ni cathode can be easily scaled up to allow large volumes of real industrial wastewater to be processed, successfully transferring nitrate into ammonia with high yields and Faradaic efficiency. This study demonstrates a new, mild, and promising method of cleaning nitrate-laden wastewater that produces ammonia as a valuable byproduct.


Subject(s)
Ammonia , Nitrates , Electrodes , Nitrogen Oxides , Wastewater
3.
Zhongguo Zhong Xi Yi Jie He Za Zhi ; 34(6): 722-7, 2014 Jun.
Article in Zh | MEDLINE | ID: mdl-25046957

ABSTRACT

OBJECTIVE: To investigate the effect of compound qingqin liquid (CQL) on Toll-like receptor 2 (TLR2) and toll-like receptor 4 (TLR4) in rats with urate nephropathy, and to explore its renal protection mechanism. METHODS: Totally 55 SD rats were randomly divided into 5 groups, i.e., the normal control group (n =5), the model group (n =10), the positive drug group (n=10), and the high-, medium-, low-dose CQL groups (n=10) respectively. The urate nephropathy model was induced by intragastrically administering adenine and feeding yeast. Distilled water was intragastrically administered at the daily dose of 10 mL/kg to rats in the normal control group and the model group. Allopurinol was intragastrically administered at the daily dose of 9.33 mg/kg to rats in the positive control group. CQL was intragastrically administered at the daily dose of 3.77, 1.89, 0.94 g/kg to rats in the high-, medium-, and low-dose CQL groups. Rats of each group were executed in batches at the 4th and 6th week respectively. Their kidney tissues were taken out to determine the mRNA transcription level of TLR2 and TLR4 by reverse transcription-polymerase chain reaction (RT-PCR). The protein expression level of TLR2 and TLR4 were determined by Western blot. The protein expression level of TLR4 was also detected by immunohistochemical assay. RESULTS: At week 4 and 6, the protein expression of TLR2 and TLR4 as well as the mRNA transcription of TLR4 increased in the model group, when compared with the control group (P < 0.05, P < 0.01). Compared with the model group, there was no statistical difference in the transcription level of TLR2 mRNA or TLR4 mRNA among the 3 CQL groups (P > 0.05) at week 4 and 6. Additionally, at week 6, the protein expression of TLR4 and TLR2 could be reduced by CQL (P < 0.05, P < 0.01). CONCLUSION: CQL might protect kidney tissue against inflammatory injury by inhibiting the protein expression levels of TLR2 and TLR4.


Subject(s)
Drugs, Chinese Herbal/pharmacology , Kidney Diseases/metabolism , Toll-Like Receptor 2/metabolism , Toll-Like Receptor 4/metabolism , Animals , Disease Models, Animal , Kidney/drug effects , Kidney/metabolism , Kidney Diseases/drug therapy , Male , RNA, Messenger/genetics , Rats , Rats, Sprague-Dawley , Toll-Like Receptor 2/genetics , Toll-Like Receptor 4/genetics , Uric Acid
4.
Zhongguo Zhong Xi Yi Jie He Za Zhi ; 34(7): 819-25, 2014 Jul.
Article in Zh | MEDLINE | ID: mdl-25137848

ABSTRACT

OBJECTIVE: To investigate the effect of Compound Qingqin Liquid (CQL) on the expression level of angiotensin II (Ang II) and COX-2 mRNA transcription and protein expression in the renal tissue of rats with uric acid nephropathy. METHODS: SD rats were randomly divided into the blank control group, the model group, the positive drug group, the high, moderate, and low dose CQL group according to number randomization principle. The model was established by gastrogavage of adenine, accompanied with yeast feeding. Distilled water was given by gastrogavage to rats in the blank control group and the model group. Allopurinol at the daily dose of 9.33 mg/kg was given by gastrogavage to rats of the positive control group. CQL at the daily dose of 3.77 g/kg, 1.89 g/kg, and 0.09 g/kg was respectively given by gastrogavage to rats in the high, moderate, and low dose CQL groups. All treatment lasted for 6 weeks. Rats were randomly divided at week 4 (3 in the blank control group, and 6 in the rest groups), and the rest rats were killed at week 6. The renal tissue was extracted. The expression level of Ang II and COX-2 mRNA transcription were detected by RT-PCR. The expression level of Ang II was detected by ELISA. The expression level of COX-2 protein was detected by Western blot and immunohistochemical assay. RESULTS: Compared with the blank control group, except the mRNA expression of Ang II at week 4, the mRNA and protein expression of Ang II and COX-2 obviously increased at week 4 and 6 in the model group (P < 0.01, P < 0.05). The COX-2 protein expression at week 4 was obviously lower in the high and moderate dose CQL groups than in the model group and the low dose CQL group (P < 0.05); the average integral of optical density value was obviously lower in the positive control group than in the model group. Except the mRNA expression of Ang II in the high dose CQL group at week 6, the mRNA and protein expression of Ang II obviously decreased in the positive control group and each dose CQL group (P < 0.01, P < 0.05). Of them, the effects were better in the high and moderate dose CQL groups than in the positive control group and the low dose CQL group (P < 0.05, P < 0.01). Besides, the mRNA expression of COX-2, the average integral of optical density value were obviously lower in the positive control group and each dose CQL group than in the model group (P < 0.05). The protein expression of COX-2 was obviously lower in the high and moderate dose CQL groups than in the model group (P < 0.05). Of them, the mRNA expression of COX-2 was better in the moderate dose CQL group than in the positive control group (P < 0.05); the protein expression of COX-2 was better in the high dose CQL group than in the low dose CQL group (P < 0.05). CONCLUSION: CQL was capable of lowering the expression level of Ang II, COX-2 mRNA transcription and protein expression, thus suppressing the inflammatory pathological injury of the renal tissue.


Subject(s)
Angiotensin II/metabolism , Cyclooxygenase 2/metabolism , Drugs, Chinese Herbal/pharmacology , Kidney Diseases/metabolism , Animals , Cyclooxygenase 2/genetics , Disease Models, Animal , Kidney/metabolism , Kidney Diseases/drug therapy , Male , RNA, Messenger/genetics , Random Allocation , Rats , Rats, Sprague-Dawley , Uric Acid
5.
IEEE J Biomed Health Inform ; 28(5): 3186-3199, 2024 May.
Article in English | MEDLINE | ID: mdl-38412074

ABSTRACT

For a long time, the prevention and control of COVID-19 has received significant attention. A crucial aspect of controlling the disease's spread is the epidemiological survey of patients and the subsequent analysis of epidemiological survey reports (case reports). However, current mainstream analysis approaches are all made manually. This manual method is time-consuming and manpower-intensive. This paper designs an automated visual epidemiological survey analysis (AVESA) framework for the epidemiological survey on COVID-19. AVESA designs a deep neural network for information extraction from case reports and automatically constructs an epidemiological knowledge graph based on predefined pattern. Moreover, a multi-dimensional knowledge reasoning model is developed for conducting knowledge reasoning in the complete COVID-19 epidemiological knowledge graph. In the entity extraction sub-task and multi-task extraction sub-task, AVESA achieved F1 scores of 85.12% and 92.29% respectively on the constructed dataset, significantly outperforming the standalone information extraction models. In full-graph computing, all three experiments align closely with manual analysis standards. In the risk analysis experiment, the weighted PageRank algorithm showed an average improvement of 11.21% in Top_Recall_n% over the standard PageRank algorithm. In the community detection experiment, the weighted Louvain algorithm showed a mere 4.34% community difference rate compared to manual analysis.


Subject(s)
Algorithms , COVID-19 , SARS-CoV-2 , Humans , COVID-19/epidemiology , COVID-19/prevention & control , Neural Networks, Computer , Data Mining/methods , Deep Learning
6.
Zhong Yao Cai ; 35(2): 254-9, 2012 Feb.
Article in Zh | MEDLINE | ID: mdl-22822673

ABSTRACT

OBJECTIVE: To study the influences of Shengbanfang on CYP3A1 activities of SD rat and provide suggestions for drug combinations. METHODS: 25 male SD rats were devided into 5 groups randomly,and treated with saline( NS, ig, 10 mg/(kg/d) ,qd,14 d), dexamethasone (DEX, ig, 100 mg/(kg x d), qd, 3 d), high dose of Shengbanfang (HD, ig, 8.645 g/kg, bid, 14 d), middle dose of Shengbanfang (MD, ig, 4.322 g/kg, bid, 14 d) and low dose of Shengbanfang (LD, ig, 2.161 g/kg, bid, 14 d), respectively. The HPLC method was established and validated to determine the productive velocity of 6beta-hydroxytestosterone and measure the activity of CYP3Al. RESULTS: Under the optimized incubation conditions, the productive rates of 6beta-hydroxytestosterone of HD, MD, LD, NS and DEX, groups were (55.82 +/- 5.97), (65.10 +/- 6.83), (60.89 +/- 6.53), (62.17 +/- 6.55), (126.73 +/- 15.40) micromol/(L x mg pro x min). There were significant differences between Shengbanfang groups compared with dexamethasone group, but there was no significant difference between Shengbanfang groups and the control group (NS). CONCLUSION: Shengbanfang has no induce effect on the enzymic activity of CYP3Al in SD rats.


Subject(s)
Cytochrome P-450 CYP3A/metabolism , Dexamethasone/pharmacology , Drugs, Chinese Herbal/pharmacology , Microsomes, Liver/enzymology , Testosterone/metabolism , Animals , Chromatography, High Pressure Liquid , Cytochrome P-450 CYP3A/drug effects , Dose-Response Relationship, Drug , Drug Combinations , Drugs, Chinese Herbal/administration & dosage , Enzyme Activation/drug effects , Hydroxytestosterones/metabolism , Male , Microsomes, Liver/drug effects , Plants, Medicinal/chemistry , Random Allocation , Rats , Rats, Sprague-Dawley , Thrombocytopenia/chemically induced , Thrombocytopenia/drug therapy
7.
Zhong Yao Cai ; 34(10): 1648-51, 2011 Oct.
Article in Zh | MEDLINE | ID: mdl-22372157

ABSTRACT

OBJECTIVE: To predict the potential molecular target proteins of Yinchenhao decocation by computer systems biology approaches. METHODS: For text mining, TCMGeneDIT was used to retrieve association information regarding genes or proteins, Artemisiae scopariae of 17 main compounds absorbed into blood after oral administration of Yinchenhao decoction, target identificetion and analysis was conducted to determine the target proteins of those compounds using PharmMapper sever. The proteins which had direct interaction with predictive target proteins were selected by screening BIND, BioGRID, DIP, HPRD, IntAct, MINT database. RESULTS: Four and eight proteins were found to respectively associate with Artemisiae scopariae herba and Rhei radix et rhizome. Six components including rhein, emodin, 6, 7-dimethoxy coumarin not only directly interacted with target proteins which were proved by experiments, but also interacted with other related proteins. Eight components such as isofradin-3-O-glycoside could only play assistant roles by interacting with related proteins. CONCLUSION: The result provides useful information for further research. It is expected it would be helpful for understanding the molecular mechanism of Yinchenhao decoction. Taken together, the protocol developed in the study may lead to a deeper understanding of a system as a whole in the mechanism of Chinses formula.


Subject(s)
Drug Design , Drugs, Chinese Herbal/chemistry , Medicine, Chinese Traditional , Plants, Medicinal/chemistry , Proteins/metabolism , Systems Biology , Data Collection/methods , Databases, Protein , Drug Combinations , Drug Synergism , Drugs, Chinese Herbal/metabolism , Drugs, Chinese Herbal/pharmacology , Humans , Proteins/chemistry
8.
Water Res ; 151: 362-370, 2019 03 15.
Article in English | MEDLINE | ID: mdl-30616048

ABSTRACT

Sulfidogenic process using sulfate-reducing bacteria (SRB) has been used to remove arsenite from the arsenic-contaminated waters through the precipitation of arsenite with sulfide. However, excessive sulfide production and significant pH increase induced by sulfate reduction result in the formation of the mobile thioarsenite by-products and the inefficiency and instability of arsenite removal, especially when the arsenite level fluctuates. In this study, we proposed a novel sulfidogenic process driven by sulfur reducing bacteria (S0RB) for the arsenite removal under acidic conditions. In a long term experiment, efficient sulfide production (0.42 ±â€¯0.2 kg S/m3-d) was achieved without changing the acidic condition (pH around 4.3) in a sulfur reduction bio-reactor. With the acidic sulfide-containing effluents from the bio-reactor, over 99% of arsenite (10 mg As/L) in the arsenic-contaminated water was precipitated without the formation of soluble thioarsenite by-products, even in the presence of excessive sulfide. Maintaining the acidic condition (pH around 4.3) of the sulfide-containing effluent was essential to ensure the efficient arsenite precipitation and minimize the formation of thioarsenite by-products when the arsenite to sulfide molar ratios ranged from 0.1 to 0.46. An acid-tolerant S0RB, Desulfurella, was found to be responsible for the efficient dissimilatory sulfur reduction under acidic conditions without changing the solution pH significantly. The microbial sulfur reduction may proceed through the direct electron transfer between the S0RB and sulfur particles, and also through the indirect electron transport mediated by electron carriers. The findings of this study demonstrate that the proposed sulfidogenic process driven by S0RB working under acidic conditions can be a promising alternative to the SRB-based process for arsenite removal from the arsenic-contaminated waters.


Subject(s)
Arsenites , Sulfur-Reducing Bacteria , Arsenamide , Bioreactors , Oxidation-Reduction , Sulfates , Sulfides
9.
Water Res ; 160: 288-295, 2019 Sep 01.
Article in English | MEDLINE | ID: mdl-31154126

ABSTRACT

The sulfidogenic process driven by sulfate-reducing bacteria (SRB) is not suitable for mercury-contaminated wastewater treatment due to the highly toxic methyl-mercury (MeHg) produced by SRB. In our previous study, we observed in short-term batch tests that sulfur-reducing bacteria (S0RB) could remove mercury ions without MeHg production. Thus, the aim of this study is to develop a biological sulfur reduction process driven by S0RB for mercury-contaminated wastewater, and investigate its long-term performance on mercury removal and MeHg accumulation. Receiving mercury-contaminated wastewater containing 0-50 mg Hg(II)/L for 326 days, S0RB in the sulfur-reducing bioreactor showed high tolerance with mercury toxicity, and removed 99.4% ±â€¯1.4% of the influent Hg(II) by biogenic sulfide. MeHg was always found to be undetectable in the bioreactor, even though the sulfidogenic bacteria were exposed to high levels of Hg(II) in long-term trials. The result of qPCR analysis further revealed that the mercury-methylation functional gene (hgcA) concentration in the bioreactor sludge was found to be extremely lower than in the SRB-enriched sludge, Geobacter sulfurreducens PCA and Desulfomicrobium baculatum DSM 4028, implying that there was no or few mercury methylators in the bioreactor. In short, the biological sulfur reduction process using S0RB can efficiently treat mercury-contaminated wastewater, with high Hg(II) removal efficiency and no MeHg accumulation.


Subject(s)
Mercury , Methylmercury Compounds , Sulfur-Reducing Bacteria , Bioreactors , Sulfur , Wastewater
10.
Ai Zheng ; 26(12): 1287-91, 2007 Dec.
Article in Zh | MEDLINE | ID: mdl-18076788

ABSTRACT

BACKGROUND & OBJECTIVE: Docetaxel is used to treat non-small cell lung cancer, breast cancer and ovarian cancer. It is indissolvable and the solvent containing polysorbate-80 and 13% solution of ethanol is used for injections. Its clinical application is limited because of frequent severe hypersensitive responses. This study was to prepare docetaxel (DOC) liposomes and investigate their pharmacokinetics in rabbits after intravenous administration. METHODS: DOC liposomes, with or without modification of polyethylene glycol (PEG), were prepared by thin-film ultrasonic dispersion method. The entrapment efficiency and mean diameter of the liposomes were measured. After intravenous administration in rabbits, plasma DOC concentration was detected by solid phase extraction high-performance liquid chromatography (SPE-HPLC). The pharmacokinetic parameters were calculated and analyzed by 3p87 pharmacokinetic program. RESULTS: The entrapment efficiency of DOC liposomes was above 75%. The mean diameter was about 150 nm. The half-life of distribution (T(1/2alpha)) were (0.17+/-0.04) h for market docetaxel injection (M-DOC), (0.31+/-0.11) h for common DOC liposome (L-DOC), and (0.32+/-0.06) h for PEG-2000-modified DOC long circulating liposome (PEG-DOC-LCL); the half-life of clearance (T(1/2beta)) were (8.54+/-1.05), (11.18+/-1.33), and (10.51+/-1.13) h, respectively; the apparent volume of distribution (V(d)) were (13.66+/-3.62), (8.65+/-1.11), and (6.31+/-0.55) L, respectively; the area under the concentration-time curve from 0 to 24 h (AUC(0-->24)) were (13.45+/-2.44), (22.83+/-3.57), and (29.31+/-5.96) mg x (h x L)(-1), respectively; the area under the concentration-time curve from 0 to infinity h (AUC(0-->infinity)) were (15.07+/-2.76), (28.70+/-4.95), and (36.95+/-9.13) mg x (h x L)(-1), respectively; the clearance (CL) were (1.10+/-0.18), (0.54+/-0.08), and (0.42+/-0.07) L/h, respectively. CONCLUSION: The thin-film prepared DOC liposomes have high entrapment efficiency and small particle size. Both liposomes, especially PEG-DOC-LCL, can raise AUC and prolong the resident time of drugs in the blood circulating system.


Subject(s)
Antineoplastic Agents/administration & dosage , Antineoplastic Agents/pharmacokinetics , Liposomes , Taxoids/administration & dosage , Taxoids/pharmacokinetics , Animals , Area Under Curve , Docetaxel , Drug Carriers , Drug Compounding , Drug Stability , Female , Injections, Intravenous , Male , Particle Size , Polyethylene Glycols , Rabbits
11.
Ai Zheng ; 25(8): 1052-8, 2006 Aug.
Article in Zh | MEDLINE | ID: mdl-16965693

ABSTRACT

BACKGROUND & OBJECTIVE: Lately, the prevention, treatment and research of cancer have developed rapidly. Antineoplastic drugs have become one of the major measures for cancer therapy. Many new antineoplastic drugs have been discovered and prepared, and used to treat tumors. Cancer Center of Sun Yat-sen University is one of the biggest cancer hospitals in South China. The use of antineoplastic drugs of this center can reflect changes in this area. This study was to analyze and evaluate the situation and trend of antineoplastic drugs used in Cancer Center, Sun Yat-sen University from 1996 and 2005, in order to provide references for the rational use of drugs in clinical application. METHODS: Consumption of antineoplastic drugs was analyzed by sum and defined daily dose (DDDs) ranking. RESULTS: The costs of antineoplastic drugs occupied 31.0%-48.8% of all drugs from 1996 to 2005; and the average increasing ratio is 21.5%. The cost rate of anti-cancer vegetable drugs and other genus increased the quickest, while the total costs of alkylate increased the slowest during the ten years. Some new monoantibodies and gene drugs were continuously applied in clinical use. CONCLUSION: The direction of the research and development of antineoplastic drugs is towards high efficiency, low toxicity and individualized use.


Subject(s)
Antibodies, Monoclonal/economics , Antimetabolites, Antineoplastic/economics , Antineoplastic Agents, Phytogenic/economics , Antineoplastic Agents/economics , Cisplatin/economics , Drug Utilization Review , Antibodies, Monoclonal/therapeutic use , Antibodies, Monoclonal, Murine-Derived , Antimetabolites, Antineoplastic/therapeutic use , Antineoplastic Agents/therapeutic use , Antineoplastic Agents, Phytogenic/therapeutic use , Carboplatin/economics , Carboplatin/therapeutic use , China , Cisplatin/therapeutic use , Cost-Benefit Analysis , Deoxycytidine/analogs & derivatives , Deoxycytidine/economics , Deoxycytidine/therapeutic use , Drug Costs/trends , Humans , Neoplasms/drug therapy , Paclitaxel/economics , Paclitaxel/therapeutic use , Rituximab , Vinblastine/analogs & derivatives , Vinblastine/economics , Vinblastine/therapeutic use , Vinorelbine , Gemcitabine
SELECTION OF CITATIONS
SEARCH DETAIL